EP3781135A4 - Compositoins pharmaceutiques solides d'administration par voie orale comprenant de la sitagliptine - Google Patents

Compositoins pharmaceutiques solides d'administration par voie orale comprenant de la sitagliptine Download PDF

Info

Publication number
EP3781135A4
EP3781135A4 EP19788122.0A EP19788122A EP3781135A4 EP 3781135 A4 EP3781135 A4 EP 3781135A4 EP 19788122 A EP19788122 A EP 19788122A EP 3781135 A4 EP3781135 A4 EP 3781135A4
Authority
EP
European Patent Office
Prior art keywords
sitagliptin
pharmaceutical compositions
solid oral
oral pharmaceutical
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19788122.0A
Other languages
German (de)
English (en)
Other versions
EP3781135A2 (fr
Inventor
Ali Turkyilmaz
Seval Ataman
Cagil ERKAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3781135A2 publication Critical patent/EP3781135A2/fr
Publication of EP3781135A4 publication Critical patent/EP3781135A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP19788122.0A 2018-04-17 2019-03-06 Compositoins pharmaceutiques solides d'administration par voie orale comprenant de la sitagliptine Pending EP3781135A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201805447 2018-04-17
PCT/TR2019/050139 WO2019203771A2 (fr) 2018-04-17 2019-03-06 Compositoins pharmaceutiques solides d'administration par voie orale comprenant de la sitagliptine

Publications (2)

Publication Number Publication Date
EP3781135A2 EP3781135A2 (fr) 2021-02-24
EP3781135A4 true EP3781135A4 (fr) 2021-12-29

Family

ID=68240633

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19788122.0A Pending EP3781135A4 (fr) 2018-04-17 2019-03-06 Compositoins pharmaceutiques solides d'administration par voie orale comprenant de la sitagliptine

Country Status (2)

Country Link
EP (1) EP3781135A4 (fr)
WO (1) WO2019203771A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020018034A2 (fr) * 2018-04-17 2020-01-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions pharmaceutiques orales comprenant un inhibiteur de dpp-4
US20230033410A1 (en) * 2019-12-24 2023-02-02 Hanmi Pharm. Co.,Ltd. Complex formulation comprising sitagliptin and dapagliflozin, and preparation method therefor
CN111481520A (zh) * 2020-06-15 2020-08-04 千辉药业（安徽）有限责任公司 一种磷酸西他列汀片剂
CN114159401A (zh) * 2021-11-18 2022-03-11 苏州天马医药集团天吉生物制药有限公司 一种磷酸西格列汀片剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295083A1 (fr) * 2009-09-15 2011-03-16 Ratiopharm GmbH Composition pharmaceutique renfermant les agents actifs metformine et sitagliptine ou vildagliptine
US20120258170A1 (en) * 2009-05-20 2012-10-11 Nutracryst Therapeutics Private Limited Pharmaceutical co-crystals of quercetin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014057059A1 (fr) * 2012-10-11 2014-04-17 Sanovel Ilac Sanayi Ve Ticaret A.S. Formulation effervescente de cefdinir
WO2014174469A1 (fr) 2013-04-25 2014-10-30 Ranbaxy Laboratories Limited Compositions pharmaceutiques comprenant une combinaison de sitagliptine et de metformine
TR201310724A2 (tr) 2013-09-12 2015-03-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Linagliptinin farmasotik formulasyonları.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120258170A1 (en) * 2009-05-20 2012-10-11 Nutracryst Therapeutics Private Limited Pharmaceutical co-crystals of quercetin
EP2295083A1 (fr) * 2009-09-15 2011-03-16 Ratiopharm GmbH Composition pharmaceutique renfermant les agents actifs metformine et sitagliptine ou vildagliptine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
N/A: "Summary of Product Characteristics Janumet 50(850mg", 9 December 2009 (2009-12-09), XP055864311, Retrieved from the Internet <URL:https://www.ema.europa.eu/en> *
See also references of WO2019203771A2 *

Also Published As

Publication number Publication date
WO2019203771A3 (fr) 2020-01-16
WO2019203771A2 (fr) 2019-10-24
EP3781135A2 (fr) 2021-02-24

Similar Documents

Publication Publication Date Title
EP3817722A4 (fr) Compositions pharmaceutiques comprenant du méloxicam
EP4045480A4 (fr) Formulations pharmaceutiques
EP3781135A4 (fr) Compositoins pharmaceutiques solides d&#39;administration par voie orale comprenant de la sitagliptine
EP3709978B8 (fr) Formulation pharmaceutique orale comprenant des bactéries
EP3851121A4 (fr) Composition pharmaceutique contenant un anticorps monoclonal anti-il-33 humain
IL285674A (en) Pharmaceutical formulations
EP3813822A4 (fr) Compositions pharmaceutiques solides d&#39;administration par voie orale comprenant du tériflunomide
EP3868371A4 (fr) Nouvelle composition pharmaceutique
IL290469A (en) Oral pharmaceutical preparation
EP3895682A4 (fr) Composition dentaire
EP3756471A4 (fr) Composition d&#39;ingestion orale
EP3796915A4 (fr) Formulations orales comprenant du rivaroxaban
EP3881841A4 (fr) Composition pharmaceutique
EP4058025A4 (fr) Compositions pharmaceutiques comprenant du ticagrelor
EP3886820B8 (fr) Formulations de capsules
EP3801539A4 (fr) Compositoins pharmaceutiques solides d&#39;administration par voie orale comprenant de la linagliptine
EP4048276A4 (fr) Formulations pharmaceutiques solides comprenant du ticagrelor
EP3817744A4 (fr) Formes d&#39;ivosidénib et compositions pharmaceutiques
EP3858322A4 (fr) Composition dentaire
EP4081251A4 (fr) Compositions pharmaceutiques
EP3914234A4 (fr) Compositions pharmaceutiques
EP3984549A4 (fr) Composition médicinale
EP4005556A4 (fr) Composition pharmaceutique comprenant de l&#39;udénafil
EP3949952A4 (fr) Composition médicinale
EP3920909A4 (fr) Compositions pharmaceutiques comprenant du méloxicam

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201027

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

A4 Supplementary search report drawn up and despatched

Effective date: 20211201

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/10 20060101ALI20211125BHEP

Ipc: A61K 31/522 20060101ALI20211125BHEP

Ipc: A61K 9/20 20060101AFI20211125BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230317

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708